ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : pathogen response
Field of Research : Medical Bacteriology
Clear All
Filter by Field of Research
Medical Bacteriology (54)
Medical Microbiology (2)
Clinical Sciences not elsewhere classified (1)
Immunology not elsewhere classified (1)
Medical Biotechnology not elsewhere classified (1)
Medicinal and Biomolecular Chemistry not elsewhere classified (1)
Filter by Socio-Economic Objective
Disease Distribution and Transmission (incl. Surveillance and Response) (2)
Expanding Knowledge in the Medical and Health Sciences (1)
Infectious Diseases (1)
Preventive Medicine (1)
Soaps and Cosmetics (1)
Filter by Funding Provider
National Health and Medical Research Council (52)
Australian Research Council (2)
Filter by Status
Closed (54)
Filter by Scheme
Project Grants (27)
NHMRC Project Grants (16)
Early Career Fellowships (5)
Career Development Fellowships (4)
Linkage Projects (2)
Filter by Country
Australia (7)
Filter by Australian State/Territory
VIC (4)
QLD (2)
NSW (1)
  • Researchers (4)
  • Funded Activities (54)
  • Organisations (11)
  • Funded Activity

    Understanding The Complex Relationship Between Host, Pathogen And Antibiotic Factors On Treatment Outcome In Serious Bacterial Infections

    Funder
    National Health and Medical Research Council
    Funding Amount
    $380,945.00
    Summary
    Millions of people still die every year from bacterial infections despite the availability of antibiotics. The same bacterial infection in one person can behave very differently in another person, so infections can range from trivial to life-threatening or fatal. Understanding the relationship between the patient, the infecting bacteria and the antibiotic treatment given will ultimately help to predict and improve outcomes for patients with serious bacterial infections.
    More information
    Funded Activity

    Development Of Novel Antimicrobial Agents

    Funder
    National Health and Medical Research Council
    Funding Amount
    $469,500.00
    Summary
    The Team brings together a unique grouping of people with backgrounds in molecular biology, medical microbiology, microbiology, marine ecology and immunology to tackle a significant health problem infections caused by bacteria. Using a novel approach, based on understanding how marine organisms specifically interfere with bacterial colonisation, the Team over the past seven years has identified a group of compounds that represent a novel group of antibiotics. Publications and patenting by the Te .... The Team brings together a unique grouping of people with backgrounds in molecular biology, medical microbiology, microbiology, marine ecology and immunology to tackle a significant health problem infections caused by bacteria. Using a novel approach, based on understanding how marine organisms specifically interfere with bacterial colonisation, the Team over the past seven years has identified a group of compounds that represent a novel group of antibiotics. Publications and patenting by the Team has demonstrated that the Team is at the forefront of research in this area. The novel antibiotics work by preventing bacteria sticking to surfaces and by preventing the bacteria from releasing toxins. The studies will concentrate on those bacteria that produce infections in the lungs (acute pneumonia), eyes (corneal infection), ear (middle ear disease), and abscesses.
    Read more Read less
    More information
    Funded Activity

    Host-pathogen Interactions In Clostridial Myonecrosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $577,573.00
    Summary
    We will analyse the interaction between the bacteria that cause gas gangrene, and the infected host, from both a host and pathogen perspective. We will examine how the host’s response to infection can be modulated to decrease the severity of disease and we will identify the biochemical processes that are essential for bacterial growth in the host, a necessary prerequisite for disease. Outcomes will be a better understanding of the mechanisms of disease causation and improved disease control.
    More information
    Funded Activity

    A Novel CD39-like Ecto-NTPDase Of Legionella Pneumophila

    Funder
    National Health and Medical Research Council
    Funding Amount
    $362,046.00
    Summary
    Legionnaire's disease is a serious cause of community acquired pneumonia. We are studying the way the Legionella bacteria persist in the environment and cause disease. We have found that Legionella produces a specific protein that mimics the action of a human protein. This proposal aims to work out how the bacteria use this protein to infect the human lung and escape killing by immune cells. The results from this study will help to determine if this protein may be used as a target for the develo .... Legionnaire's disease is a serious cause of community acquired pneumonia. We are studying the way the Legionella bacteria persist in the environment and cause disease. We have found that Legionella produces a specific protein that mimics the action of a human protein. This proposal aims to work out how the bacteria use this protein to infect the human lung and escape killing by immune cells. The results from this study will help to determine if this protein may be used as a target for the development of new anti-infective drugs.
    Read more Read less
    More information
    Funded Activity

    Nasal Epithelium As A Portal Of Entry For Burkholderia Pseudomallei, With Special Reference To Neurological Melioidosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $536,419.00
    Summary
    Melioidosis is a potentially fatal disease of manly tropical Australia and SE Asia and an emerging disease worldwide. It disproportionately affects indigenous Australians. It is caused by a bacterium found in soil and water and infection may be by inhalation in the rainy season. One manifestation of melioidosis is neurological symptoms. This project seeks to establish sites and pathways of infection resulting from inhalation, including the pathway from nasal mucosa to brain.
    More information
    Funded Activity

    Utilisation Of The Human Plasminogen Activation System By Group A Streptococci: Contribution To Virulence And Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $254,250.00
    Summary
    Streptococcus pyogenes (group A streptococci; GAS) is a bacterium which causes human skin and throat infections as well as highly invasive diseases including the flesh eating disease necrotising fasciitis. Additionally, serious sequelae, including rheumatic fever and acute glomeulonephritis, may result following infection. Such diseases cause high morbidity and mortality in Aboriginal populations and are a continual significant drain on the national health fund. An important mode of invasion by .... Streptococcus pyogenes (group A streptococci; GAS) is a bacterium which causes human skin and throat infections as well as highly invasive diseases including the flesh eating disease necrotising fasciitis. Additionally, serious sequelae, including rheumatic fever and acute glomeulonephritis, may result following infection. Such diseases cause high morbidity and mortality in Aboriginal populations and are a continual significant drain on the national health fund. An important mode of invasion by GAS may be related to their ability to capture and activate host plasminogen via surface-associated or secreted plasminogen binding proteins (receptors). Plasminogen can be activated by host activators or secreted GAS streptokinase to the potent enzyme plasmin which is responsible for the degradation of tissue barriers. Thus, GAS may utilise plasmin to destroy tissue barriers and invade host tissues. The characterisation of the interaction between GAS and the plasminogen activation system would clarify the role of this system in invasive disease and provide potential targets for therapeutic intervention.
    Read more Read less
    More information
    Funded Activity

    Functional Characterisation Of The SseK/NleB Family Of Type III Secreted Effectors In Salmonella And E. Coli

    Funder
    National Health and Medical Research Council
    Funding Amount
    $510,183.00
    Summary
    Salmonella and E. coli cause enteritis and diarrhoea in a large proportion of the world's population including Australia. Certain strains of Salmonella also cause a more serious disease called typhoid fever. Together, diseases caused by Salmonella and E. coli are a major cause of illness and death. In order to cause disease Salmonella and E. coli use a specialised apparatus that functions like a needle and syringe to inject Salmonella proteins into human cells. These proteins that are injected i .... Salmonella and E. coli cause enteritis and diarrhoea in a large proportion of the world's population including Australia. Certain strains of Salmonella also cause a more serious disease called typhoid fever. Together, diseases caused by Salmonella and E. coli are a major cause of illness and death. In order to cause disease Salmonella and E. coli use a specialised apparatus that functions like a needle and syringe to inject Salmonella proteins into human cells. These proteins that are injected into human cells actively reprogram human cells to benefit the disease causing bacteria. We have recently discovered a new family of injected proteins and we aim to determine how these new proteins reprogram human cells and what this contributes to diarrhoea and typhoid fever. This information may lead to the development of more effective treatments for these important diseases.
    Read more Read less
    More information
    Funded Activity

    Inhibition Of Haemostasis As A Novel Host-directed Therapy For Tuberculosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $528,471.00
    Summary
    Mycobacterium tuberculosis-induced vasculopathy is an important cause of stroke worldwide, and stroke is a common (~20%) complication of tuberculous meningitis, the most dangerous presentation of tuberculosis. Blood clotting may also speed the growth tuberculosis in the body further worsening the situation. We will use zebrafish find out if clotting can be targeted to slow the growth of mycobacteria and then translate our findings to a mouse model of pulmonary tuberculosis.
    More information
    Funded Activity

    Genes Of Mycobacterium Tuberculosis Essential For Latent Tuberculosis Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $590,103.00
    Summary
    One third of the worlds population is latently infected with M. tuberculosis, the bacteria which causes TB. We have identified key genes in M. tuberculosis that enable the bacterium to shut-down and become latent. This project will investigate these genes, identify their role and yield vital information for a new paradigm of drug and vaccine development. Improved vaccines and drugs which can target and inhibit latency would be of enormous benefit to the global community.
    More information
    Funded Activity

    Novel Perspectives On The Function Of AB5 Toxin B Subunits

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,041,896.00
    Summary
    AB5 toxins are important virulence factors of pathogenic bacteria. They comprise pentameric B subunits that bind to target cell surfaces and catalytic A subunits that damage host cell functions. This proposal examines a new paradigm wherein the B subunits are significant contributors to cell damage. We will characterize the cytopathic properties of diverse B subunits, particularly those of emerging toxins. This will provide novel insights into pathogenesis and inform development of therapeutics.
    More information

    Showing 1-10 of 54 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback